Sage Journals: Discover world-class research

Open access

Review article

First published 2025-7

Discriminating evidence – use and misuse of the drug-discrimination test in abuse potential assessment of novel CNS drugs

David J Heal, Sharon Lesley Smith, Jane Gosden [...]

Journal of Psychopharmacology

Retricted access

Research article

First published 1975-10

Interactions of CNS Drugs: Psychotherapeutic Agents—The Antipsychotic Drugs

Edward A. Hartshorn

Annals of Pharmacotherapy

Free access

Research article

First published 1983-11

Chronopharmacology and Chronotoxicology of CNS Drugs: Interrelationships with Neuromodulators

Charles A. Walker, Magdi R.I. Soliman, Karam F.A. Soliman

International Journal of Toxicology

Retricted access

Brief report

First published 2024

Iatrogenic Epileptogenicity Caused by CNS Drugs: A Short Case Series and Narrative Review

Annalisa Morgan, Vineet Punia

The Neurohospitalist

Open access

Research article

First published 2016-7-13

AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders

Alexandre V. Ivachtchenko, Yan Lavrovsky, Ilya Okun

Journal of Alzheimer’s Disease

Retricted access

Research article

First published 2021

Nonclinical abuse liability testing of new CNS-active drugs: Role of sex as a critical factor for drug scheduling

David V Gauvin, Zachary J Zimmermann, Mary Jeanne Kallman

Drug Science,Policy and Law

Retricted access

Research article

First published 2002-8

CNS and Psychiatric Drugs

Joyce A. Generali

Hospital Pharmacy

Retricted access

Research article

First published 2002-12

Predicting CNS Permeability of Drug Molecules: Comparison of Neural Network and Support Vector Machine Algorithms

Scott Doniger, Thomas Hofmann, Joanne Yeh

Journal of Computational Biology

Free access

Research article

First published 2014-6

Vascular Action as the Primary Mechanism of Cognitive Effects of Cholinergic,CNS-Acting Drugs,a Rat phMRI BOLD Study

Pál Kocsis, István Gyertyán, János Éles [...]

Journal of Cerebral Blood Flow & Metabolism

Free access

Other

First published 2011-6

Activating PKC-β1 at the blood—brain barrier reverses induction of P-glycoprotein activity by dioxin and restores drug delivery to the CNS

Xueqian Wang, Brian T Hawkins, David S Miller

Journal of Cerebral Blood Flow & Metabolism

Search results